Treatment with orlistat in conjunction with lifestyle changes decreases the rate of type 2 diabetes in obese patients with impaired glucose tolerance (IGT) or metabolic syndrome.

The first patent for a method of delivering normal genes in a pill to induce the production of insulin in people with diabetes was issued May 1 to the University of California, San Francisco.

We’re learning that people who are living with a chronic condition really require an approach to medical care that is different than the acute care model.”

Patients had a mean weight loss of 26 pounds when the study was ended.

Strict glucose control in type 1 diabetes reduces the risk of atherosclerosis, a benefit that persists for years.

Islet-alone transplantation is safe and effective, and the Edmonton Protocol used to accomplish this can be safely replicated.

Obesity may mediate early stages of subclinical atherosclerotic disease in patients with type 2 diabetes, whereas hyperglycemic and insulin resistance may contribute to the progression of later stages.

Two measurements may represent distinct phenotypic pathways in the evolution of type 2 diabetes, new research suggests.

New Target for Antidiabetic Agents Identified U.S. researchers identify a protein that could serve as a new target for drugs designed to treat type II diabetes. The protein, known as TRB3, is actually a homolog of a protein found in the fruit fly Drosophila tribbles, senior author Dr. Marc Montminy, …

Walking Less Then 20 Minutes A Day! Reduces Risk of Heart Disease 61% Moderation is the key to sustaining exercise. Two studies show that exercise for less than 20 minutes a day and in moderation can reduce the risk of heart disease by 61%The first study shows that physical activity …